Target intelligence / Profile preview

Dynein axonemal assembly factor 1 (DNAAF1)

Target
DNAAF1
Molecular classification
Other (Ciliary assembly factor, Protein co-chaperone, Leucine-rich repeat-containing protein)
01

Overview

Dynein axonemal assembly factor 1 (DNAAF1), also known as LRRC50, is a cytoplasmic, cilium-specific protein essential for the pre-assembly of both inner (IDA) and outer dynein arms (ODA) in motile cilia[1][2][3]. DNAAF1 interacts with components such as IFT88, RUVBL1, and RUVBL2, facilitating correct dynein arm assembly and localization[1]. Mutations in DNAAF1 cause primary ciliary dyskinesia (PCD), characterized by defective ciliary motion, leading to chronic respiratory disease, recurrent infections, laterality defects (heterotaxy/congenital heart disease), and male infertility[1][2][3]. The protein is expressed mainly in ciliated epithelia of the airways, lungs, and testis, focusing at the ciliary basal body and spindle poles in mitotic cells[2]. Genetic defects in DNAAF1 lead to absent or misassembled dynein arms, disorganized ciliary axonemes, and loss of ciliary motility, underpinning PCD pathophysiology[1][2]. DNAAF1 may also be involved in left-right patterning and axoneme backbone regulation[2]. No drugs are known to interact directly with DNAAF1, and the primary therapeutic interest lies in understanding its role in ciliary biogenesis and as a diagnostic biomarker for PCD subtypes[2][3].

Other names
LRRC50FLJ25330ODA7CILD13swtDAU1Leucine-rich repeat-containing protein 50outer row dynein assembly 7 homolog (Chlamydomonas)testicular tissue protein Li 110
02

Biological functions

Ciliary motility and formationDynein arm (outer and inner) pre-assemblyRegulation of microtubule-based cilia and actin-based microvilliSymmetry breaking in embryonic developmentCiliogenesis
03

Disease associations

Primary ciliary dyskinesiaCongenital heart disease (heterotaxy)Neural tube defects (less established)
04

Safety considerations

Loss-of-function causes severe respiratory and laterality defectsNo reported therapeutic agents, but gene dysfunction is associated with fatal lung and heart complications in PCD patients[2]
05

Biomarkers

Loss/mutations of DNAAF1 for diagnosis of primary ciliary dyskinesia-13

Beyond the preview

Go deeper on Dynein axonemal assembly factor 1 (DNAAF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dynein axonemal assembly factor 1 (DNAAF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call